Disclaimer: This animation is part of a series of animations on a MSer website, called “MS and Our Story“; I note the site is sponsored by Novartis. Novartis are a Pharma Company that produce and market a drug called Gilenya (Fingolimod) that is licensed to treat relapsing forms of MS.
“Should we rebrand MS as dementia? Have your say?“
“What do you think of this of short animation? It tries to explain the impact of MS on the brain; in the other words the early phases of MS Dementia.”